A large phase 3 clinical trial has revealed promising results for a once-nightly pill designed to treat obstructive sleep apnea by targeting the biological mechanisms that cause airway collapse during sleep. A once-nightly pill significantly improved obstructive sleep apnea (OSA) symptoms in a large phase 3 clinical trial presented at the 2026 ATS International Conference. [...]

Severe, hard-to-control blazes in densely populated areas like Los Angeles drove the year’s record losses.

Severe, hard-to-control blazes in densely populated areas like Los Angeles drove the year’s record losses.

© Loren Elliott for The New York Times